RecruitingNCT04347200

REGistry of Long-term AnTithrombotic TherApy-1

Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndromes

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Enrollment

2,000 participants

Start Date

Jan 15, 2015

Study Type

OBSERVATIONAL

Conditions

Peripheral Artery Disease Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

Eligibility

Min Age: 18 Years

Inclusion Criteria1

coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

Exclusion Criteria7

Subjects who are unwilling or unable to provide informed consent.
Acute coronary syndrome within 12 months before inclusion
Severe chronic heart failure (NYHA IV)
Stroke within 6 months before inclusion
Severe liver or muscle disease
Severe kidney disease / renal failure with creatinine > 3 mg/dl
Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAntiplatelet Drug

single or dual antiplatelets, triple antithrombotic therapy

Locations(1)

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04347200

Related Trials

Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease

NCT072832891 location

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

NCT038450361 location